Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.59 +0.02 (+0.06%)
Streaming Delayed Price Updated: 11:48 AM EDT, Aug 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,086,097
Open 24.66
Bid (Size) 24.59 (47)
Ask (Size) 24.60 (35)
Prev. Close 24.58
Today's Range 24.47 - 24.77
52wk Range 20.91 - 30.43
Shares Outstanding 5,606,688,356
Dividend Yield 6.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is Undervalued
According to a Bloomberg report, Pfizer has requested that the approval stay in place through the coming fall season. 
Via Stocktwits
Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients
Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for cisplatin therapy. 
Via Benzinga

Performance

YTD
-7.6%
-7.6%
1 Month
-3.0%
-3.0%
3 Month
+6.5%
+6.5%
6 Month
-4.9%
-4.9%
1 Year
-13.6%
-13.6%

More News

Read More
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
Via FinancialNewsMedia
Topics Artificial Intelligence
Wall Street Has Mixed Opinions On Future Of Arvinas’ Investigational Drug: Retail’s Got A Cautious Approach
Via Stocktwits
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
From Pfizer Inc.
Via Business Wire
Trading Radar For August 12: Hindalco, Adani Enterprises, Bata, Pfizer, Ashoka Buildcon, And Inox Green Are On Stocks Watchlist
Via Stocktwits
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Topics Intellectual Property
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
Via The Motley Fool
Topics Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Monday's session.
Via Chartmill
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Via Benzinga
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
Via Benzinga
3 Large-Cap Stocks with Promising Prospects
Via StockStory
2 Stocks to Buy With $5,000 and Hold for a Decade
Via The Motley Fool
2 Beaten-Down Stocks to Buy and Hold
Via The Motley Fool
Topics Intellectual Property
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
Via The Motley Fool
Topics Government World Trade
Positive Gems Becomes the World’s Most Followed Modern Pharmaceutical Brand
Via Get News
Topics Intellectual Property
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid
Via StockStory
Viatris (NASDAQ:VTRS) Beats Q2 Sales Targets, Stock Soars
Via StockStory
Upcoming Earnings Calls This Week: August 4th - August 10th, 2025
Via MarketMinute
Topics Artificial Intelligence Economy
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
Via MarketMinute
Topics Economy Government Stocks
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
Via MarketMinute
Topics Economy
OPKO Health (OPK) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.59
When was Pfizer last traded?
The last trade of Pfizer was at 08/12/25 11:48 AM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 137.90B
How many shares of Pfizer are outstanding?
Pfizer has 138B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.